These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

844 related items for PubMed ID: 19952979

  • 1. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
    Mrozek-Budzyn D, Kiełtyka A, Majewska R.
    Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
    [Abstract] [Full Text] [Related]

  • 2. [Lack of association between MMR vaccination and the incidence of autism in children: a case-control study].
    Mrozek-Budzyn D, Kiełtyka A, Majewska R.
    Przegl Epidemiol; 2009 May; 63(1):107-12. PubMed ID: 19522237
    [Abstract] [Full Text] [Related]

  • 3. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.
    Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N.
    Vaccine; 2012 Jun 13; 30(28):4292-8. PubMed ID: 22521285
    [Abstract] [Full Text] [Related]

  • 4. An epidemiological study on Japanese autism concerning routine childhood immunization history.
    Takahashi H, Suzumura S, Shirakizawa F, Wada N, Tanaka-Taya K, Arai S, Okabe N, Ichikawa H, Sato T.
    Jpn J Infect Dis; 2003 Jun 13; 56(3):114-7. PubMed ID: 12944678
    [Abstract] [Full Text] [Related]

  • 5. A population-based study of measles, mumps, and rubella vaccination and autism.
    Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M.
    N Engl J Med; 2002 Nov 07; 347(19):1477-82. PubMed ID: 12421889
    [Abstract] [Full Text] [Related]

  • 6. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
    Bernsen RM, van der Wouden JC.
    Pediatr Allergy Immunol; 2008 Sep 07; 19(6):544-51. PubMed ID: 18266826
    [Abstract] [Full Text] [Related]

  • 7. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2006 Jan 07; 27(1):63-9. PubMed ID: 16432596
    [Abstract] [Full Text] [Related]

  • 8. Measles, mumps and rubella: control by vaccination.
    van Druten JA, de Boo T, Plantinga AD.
    Dev Biol Stand; 1986 Jan 07; 65():53-63. PubMed ID: 3556777
    [Abstract] [Full Text] [Related]

  • 9. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M, Pattison HM.
    Br J Gen Pract; 2000 Dec 07; 50(461):969-71. PubMed ID: 11224968
    [Abstract] [Full Text] [Related]

  • 10. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R, Svensson E, Trollfors B, Borres MP.
    Acta Paediatr; 2004 Sep 07; 93(9):1232-7. PubMed ID: 15384890
    [Abstract] [Full Text] [Related]

  • 11. [MMR vaccination and autism--a population-based follow-up study].
    Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M.
    Ugeskr Laeger; 2002 Dec 02; 164(49):5741-4. PubMed ID: 12523209
    [Abstract] [Full Text] [Related]

  • 12. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [Abstract] [Full Text] [Related]

  • 13. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 10; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 10; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 16. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.
    Pediatrics; 2006 Jul 10; 118(1):e139-50. PubMed ID: 16818529
    [Abstract] [Full Text] [Related]

  • 17. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection.
    Olesen AB, Juul S, Thestrup-Pedersen K.
    Acta Derm Venereol; 2003 Jul 10; 83(6):445-50. PubMed ID: 14690341
    [Abstract] [Full Text] [Related]

  • 18. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N, Jansson UB, Alm B.
    Vaccine; 2006 Jul 26; 24(31-32):5800-5. PubMed ID: 16765490
    [Abstract] [Full Text] [Related]

  • 19. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 20. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Apr 25; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.